International Rare Disease Patent Applications Published in February 2021

Posted on
These PCT patent documents covering potential treatments, diagnostics, or animal and cell culture models for rare diseases as a central theme have been extracted from the WIPO PatentScope database. Abstracts are as published. This a free H. M. Pharma Consultancy service; please cite it if you use it as a starting point for your own research. Nothing in this post should be constructed as represent...
Read More

International Rare Disease Patent Applications Published in January 2021

Posted on
These PCT patent documents covering potential treatments, diagnostics, or animal and cell culture models for rare diseases as a central theme have been extracted from the WIPO PatentScope database. Abstracts are as published. This a free H. M. Pharma Consultancy service; please cite it if you use it as a starting point for your own research. Nothing in this post should be constructed as represent...
Read More

International Rare Disease Patent Applications Published in December 2020

Posted on
These PCT patent documents covering potential treatments, diagnostics, or animal and cell culture models for rare diseases as a central theme have been extracted from the WIPO PatentScope database. Abstracts are as published. This a free H. M. Pharma Consultancy service; please cite it if you use it as a starting point for your own research. Nothing in this post should be constructed as represent...
Read More

International Rare Disease Patent Applications Published in November 2020

Posted on
These PCT patent documents covering potential treatments, diagnostics, or animal and cell culture models for rare diseases as a central theme have been extracted from the WIPO PatentScope database. Abstracts are as published. This a free H. M. Pharma Consultancy service; please cite it if you use it as a starting point for your own research. Nothing in this post should be constructed as represent...
Read More

Boosting into the post-Covid era

2020… Ah, what a ride. And no, this is not another text piece joining the chorus of weeping, complaining, and interpreting how the Covid-19 pandemic has devastated drug developers – except those who had an approved antiviral drug available that had some effect against SARS-CoV2. And of course, except those who suddenly fell in love with drug repurposing and actually identified a marketed drug ...
Read More

A Summary of Recent Drug Repurposing Patent Applications (Part II)

We continue our series with a summary of the Q1/2019 drug repurposing patent discussions in ASSAY and Drug Development Technologies (ahead of print, DOI link here).   WO/2019/004808 (Université Mohammed V Rabat (Morocco) Pyridostigmin restores peripheral nervous system balance in neurodegenerative diseases or after neurotrauma WO/2019/008141 INSERM, CNRS, Université Paris Descarte...
Read More

A Summary of Recent Drug Repurposing Patent Applications (Part I)

Long time no post here. Still no narrative blogpost b/c virtually all our activities are client-confidential – sorry. But here is a synopsis of the drug repurposing patent discussions that you can soon read in full, in ASSAY and Drug Development Technologies. We shall start with documents published during Q4/2018. Remember, this is only a selection – there are many more that are interesting but di...
Read More

Some Drug Repurposing Patent Documents Published in Q3 2018

This is what to look for in the December 2018 issue of ASSAY and Drug Development Technologies: WO/2018/126000 (Rush University Medical Center, USA) Fibrates (in particular, gemfibrozil) are claimed for LINCL Type 2, a subtype of Batten disease. Much prior art here, some of it ffrom the inventors themselves. WO/2018/126192 (Childrens’ Medical Center Corp., USA) Congenital arteriovenous malform...
Read More

Patent Discussions Expand to MedChemNet

Patent Discussions Expand to MedChemNet
The Pharmaceutical Patent Analyst, the Future Science Group journal for all matters related to intellectual property in the life sciences, has been publishing H.M. Pharma Consultancy's Patent Highlights since the journal's inception in 2012, and this will continue in 2018. We are delighted to announce that MedChemNet, the premiere network for the medicinal chemistry community where researchers sh...
Read More

In the Mirror of Patenting: A Glimpse of the 2017 Drug Repurposing Theatre

Along the lines that have been discussed in a recent Frontiers short paper, here is a list of our patent discussions in the December 2017 drug repurposing special issue of ASSAY and Drug Development Technologies: WO/2017/059389 (Kythera Biopharmaceuticals, USA): Statins as an alternative to liposuction and cryolipolysis WO/2017/060308 (AB Science, France): Masitinib switches to human use WO/201...
Read More